课题基金 / 基金详情

Study on Strategies for Non-Heart Beating Liver

Study on Strategies for Non-Heart Beating Liver
肝脏无心跳治疗策略研究
批准号:
11470137
负责人:
FUJIWARA Kenji
金额:
$4.54万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

FUJIWARA Kenji的其他基金

相似基金

相关文献

中文摘要
翻译
肝窦内皮细胞(SEC)损伤是非心脏供者肝移植的主要异常。在原代培养中,血管内皮生长因子是维持和增殖血管内皮生长因子的重要因素。我们发现VEGF也通过上调SECs的孔隙度而发挥无血管通透性因子的作用。此外,VEGF可抑制肝窦星状细胞、周细胞的收缩,提示VEGF可调节肝窦微循环。UW溶液冷保存后,大鼠肝脏肝细胞中VEGF表达增加,但在SEC形成之前,VBGFR-1和VEGFR-1 mRNA表达减少。这可能表明VEGF不能有效作用于冷保存肝脏中的SEC,外源VBGF不能阻止SEC的损伤。这种激活导致了这种肝脏原位移植后的SEC损伤。我们发现活化的Kupffer细胞表达骨桥蛋白,这是Th1免疫反应启动的必要细胞因子。此外,我们利用具有不同骨桥蛋白基因等位基因的小鼠,证明骨桥蛋白作为一种趋化因子在巨噬细胞向肝脏迁移中发挥了重要作用,这表明调节Kupffer细胞中骨桥蛋白的表达可能是保护SECs的另一种策略。我们利用人血清淀粉样蛋白P组分启动子作为肝细胞特异性载体,制备了在肝脏中高度表达骨桥蛋白的转基因小鼠,以证明我们的假设的研究正在进行中
英文摘要
Sinusoidal endothelial cell (SEC) injury is a major abnormality in the liver transplanted from non-heart beating donors. It is important to protect SECs for the establishment of non-heartbcating liver transplantationVEGF is a factor essential for maintenance as well as proliferation of SECs in primary culture. We demonstrated that VEGF also acted as avascular permeability factor through up-regulation of the porosity on SECs. Furthermore, VEGF inhibited contraction of stellate cells, pericytes of SECs, suggesting that VEGF can regulate microcirculation in the hepatic sinusoids. VEGF expression in hepatocytes was increased in rat liver after cold preservation in UW solution, but mRNA expressions of VBGFR-1 and VEGFR-1 were decreased prior to the development of SEC in jury These results may suggest that VEGF cannot work effectively on SECs in the cold preserved liver, and also that exogenous VBGF cannot prevent SEC from injuryKupffer cells were markedly activated in the cold preserved liver, and this activation contributed to SEC injury after orthotopic transplantation of such livers. We found that activated Kupffer cells expressed osteopontin an essential cytokine for initiation of Th1 immune response. Also, we demonstrated that osteopontin played a major role as a chemokine in macrophage migration into the liver using mice with different alleles of osteopontin gene, suggesting that the modulation of osteopontin expression in Kupffer cells may be another strategy for protection of the SECs. We made transgenic mice expressing osteopontin very highly in the liver using human serum amyloid P component promotor as a vector specific for hepatocytes Investigations to prove our hypothesis are now in progress
期刊论文(96)
专著(0)
科研奖励(0)
会议论文
Fujimori K, Mochida S, Matsui A, Ohno A, Fujiwara K.: "Possible mechanisms of evaluation of serum transaminase levels during interferon-β therapy in chronic hepatitis C patients"J Gastroenterol. 7. 40-46 (2002)
Fujimori K、Mochida S、Matsui A、Ohno A、Fujiwara K.:“慢性丙型肝炎患者干扰素-β 治疗期间血清转氨酶水平评估的可能机制”J Gastroenterol。 7. 40-46 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Niimi Y, Mochida S, Matsui A, mao M, FujiwaraK.: "PKC-and MAPK-independent upregulation of VEGF receptor expressions in human umbilical venous endothelial cells following VEGF stimulation"Hepatology Res. 21. 261-267 (2001)
Niimi Y、Mochida S、Matsui A、mao M、Fujiwara K.:“VEGF 刺激后人脐静脉内皮细胞中 VEGF 受体表达的 PKC 和 MAPK 独立上调”肝病学研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Fujiwara K, Mochida S: "Etiology and pathophysiology of fulminant hepatic failure"Molecular Biology and Immunology for the Treatment of Intractable Liver Diseases, Tsuji T, et al.(eds), Elsevier Science, Amsterdam. 275-284 (2002)
Fujiwara K、Mochida S:“暴发性肝衰竭的病因学和病理生理学”治疗顽固性肝病的分子生物学和免疫学,Tsuji T 等人(编),Elsevier Science,阿姆斯特丹。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Funyu J, Mochida S, Inao M, Matsui A, Fujiwara K.: "VEGF can act as vascular permeability factor in the hepatic sinusoids through upregulation of porosity of endothelial cells."Biochem Biophys Res Commun. 280. 481-485 (2001)
Funyu J、Mochida S、Inao M、Matsui A、Fujiwara K.:“VEGF 可以通过上调内皮细胞的孔隙率作为肝窦中的血管通透性因子。”Biochem Biophys Res Commun。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 57 条
    Suppression of Pancreatic cancer neural invasion by regulation of Axon guidance molecule
    • 批准号:
      20K22817
    • 项目类别:
      Grant-in-Aid for Research Activity Start-up
    • 资助金额:
      $1.83万
    • 财政年份:
      2020
    • 负责人:
      FUJIWARA Kenji
    • 依托单位:
    NQR Study of Superconducting Mechanism mediated by Valence Fluctuations
    • 批准号:
      21540338
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      FUJIWARA Kenji
    • 依托单位:
    Genetic Polymorphisms in Promoter Regions of Osteopontin Gene as Host Factors to Determine Th1 Immune Reactions against Hepatitis Virus.
    • 批准号:
      14370191
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.35万
    • 财政年份:
      2002
    • 负责人:
      FUJIWARA Kenji
    • 依托单位:
    New devices in anticoagulant therapy for massive hepatic necrosis through sinusoidal fibrin deposition
    • 批准号:
      06454258
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $4.67万
    • 财政年份:
      1994
    • 负责人:
      FUJIWARA Kenji
    • 依托单位:
    海外基金